A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma

NCT01591135 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

436

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Paclitaxel plus 5-fluorouracil
DRUG: Cisplatin plus 5-fluorouracil
RADIATION: Radiation therapy
RADIATION: Radiation therapy

Sponsor

Fudan University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]